Skip to content
Wednesday, March 29, 2023
Latest:
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
  • PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
  • MindMed Announces Inclusion in FTSE Russell Indexes
Biotech Stock Market News

Biotech Stock Market News

Know First, Act First

  • Cannabis & Cancer
  • General
  • Coronavirus
  • Financing & Fiscal
  • Shareholders

Shareholders

BIOTCHNO Shareholders 

ESSA Pharma to Present at Upcoming March Investor Conferences

February 25, 2021May 17, 2021 Raza

Canada NewsWire HOUSTON, Texas and VANCOUVER, Canada, Feb. 25, 2021 /CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a

Read more
BIOTCHNO Shareholders 

Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute With Azpa Pharmaceuticals Pty. Ltd.

February 18, 2021April 30, 2021 Bachittar

Canada NewsWire LAVAL, QC, Feb. 18, 2021 /PRNewswire/ – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully

Read more
BIOTCHNO Shareholders 

ESSA Pharma Announces Proposed Public Offering of Common Shares

February 16, 2021April 30, 2021 Bachittar

Canada NewsWire VANCOUVER, BC and HOUSTON, Feb. 16, 2021 /PRNewswire/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on

Read more
BIOTCHNO Shareholders 

Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF

February 12, 2021April 30, 2021 Bachittar

  Canada NewsWire TORONTO,Feb. 12, 2021/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased

Read more
BIOTCHNO Shareholders 

QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials

December 30, 2020April 30, 2021 Desiree Justice

  QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials New Global Industry Coalition That

Read more
BIOTCHNO Shareholders 

Ultrack Systems Acquires Key GPS Tracking Solutions Provider

December 1, 2020April 30, 2021 vanessa

Ultrack Systems Acquires Key GPS Tracking Solutions Provider  Concord, Ontario–(Newsfile Corp. – December 1, 2020) – Ultrack Systems Inc. (OTC

Read more
BIOTCHNO Shareholders 

Sirona Biochem Releases CEO Letter to Shareholders

November 30, 2020April 30, 2021 vanessa

Canada NewsWire VANCOUVER, BC, Nov. 30, 2020 VANCOUVER, BC, Nov. 30, 2020 /CNW/ – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”)

Read more
BIOTCHNO Shareholders 

Neptune Wellness Solutions Inc. to ship first commercial batch of Mood Ring(TM) in Canada

November 25, 2020April 30, 2021 vanessa

Canada NewsWire LAVAL, QC, Nov. 25, 2020 ~ Landmark moment for the Company and its proprietary cannabis line as it

Read more

Cannabis

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
BIOTCHNO Cannabis & Cancer 

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan

March 31, 2021July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co.,

The Valens Company Expands Cannabis 2.0 & 3.0
BIOTCHNO Cannabis & Cancer 

The Valens Company Expands Cannabis 2.0 & 3.0

February 25, 2021April 20, 2021 Bachittar
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
BIOTCHNO Cannabis & Cancer 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar
ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
BIOTCHNO Cannabis & Cancer 

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479